Stop Waiting on New Covid-19 Treatments. Wear a Mask.

Bloomberg News (Bloomberg Opinion) — Covid-19 antibody therapies, drugs that mimic the body’s response to infection, have been hailed as a “bridge to a vaccine.” They can’t get us there alone.  Eli Lilly & Co.’s entrant in this category hit a…

Eli Lilly CEO Dave Ricks still confident in Covid antibody treatment

Kevin Stankiewicz Eli Lilly Chairman and CEO Dave Ricks told CNBC on Tuesday that he believes the company’s coronavirus antibody treatment will still be beneficial to Covid-19 patients, despite the recent end to a study of the drug in…

Pfizer Stock Is Lower Because the Covid-19 Vaccine Looms Over Earnings

Bill Alpert Text size Drug giant Pfizer is getting close to knowing whether its Covid-19 vaccine is safe and effective. But meanwhile third-quarter earnings show the drug giant hasn’t reignited growth, yet. Jeenah Moon/Getty Images After giving shots…

Scientists find signs of waning antibody immunity to COVID-19 over time in England

CBC Antibodies against the novel coronavirus declined rapidly in the population in England during the summer, according to a preprint posted on Tuesday, suggesting protection after infection may not be long-lasting and raising the prospect of waning immunity in…

COVID-19 patient better after receiving similar treatment as Trump

New York Post A woman in Wales said she was feeling “much better” after receiving the same experimental antibody treatment for the coronavirus that President Trump did during his recent bout with the illness, according to a report….

Russia coronavirus: Reality bites for Putin’s Sputnik V vaccine, as concerns over efficacy and safety linger

Mary Ilyushina and Frederik Pleitgen, CNN Putin, who is famously secretive about his family, said one of his daughters had already been inoculated as part of the early-stage trials and felt “well,” to bulk up the vaccine’s safety…

Pfizer earnings report touts coronavirus vaccine progress in 42,000-participant clinical trial

Evie Fordham President Trump on coronavirus treatments and plans to distribute the vaccine when it is approved. American pharmaceutical company Pfizer Inc. touted in its earnings report Tuesday that nearly 36,000 people have received a second vaccination in its coronavirus…

No news on Pfizer’s Covid-19 vaccine is good news — and bad news

Matthew Herper Pfizer revealed Tuesday that researchers have not yet conducted an analysis of the efficacy of the vaccine it is developing against Covid-19. The announcement is both good news and bad news.  Umer Raffat, a senior managing…

Will there be a COVID vaccine before 2021? What you need to know

Dale Smith Experts are hopeful that a vaccine against the SARS-CoV-2 virus will become available sooner rather than later. SOPA Images/Getty Images For the most up-to-date news and information about the coronavirus pandemic, visit the WHO website. When…

Enlivex to Host COVID-19 Webinar: The Staging of a New Disease and Its Implications for Treatment Options, with Mount Sinai Key Opinion Leader | 2020-10-27 | Press Releases

Stockhouse.com * Findings and Analyses On 68,000 COVID-19 Patients Discussed in the Webinar on Thursday, November 5 th @ 10amET * Nes Ziona, Israel, Oct. 27, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a…